• China Stocks Rise for Fifth Day, Longest Streak in Three Months
  • Novartis Sees MorphoSys Muscle-Atrophy Drug as Exciting
  • ‘Love Hormone’ Promises Safer Births After Pfizer Flop
  • Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’
  • Actavis to Buy Warner Chilcott in Women’s Health Effort
  • Royalty Pharma Raises Elan Bid to $12.50 a Share in Cash
  • Vitamins That Cost Pennies a Day Seen Delaying Dementia
  • XenoPort Sinks as Spasticity Drug For MS Fails in Trial
  • Merck Insomnia Drug Safer at Lower Dose, FDA Staff Says
  • Elan Makes Two Acquisitions for $380 Million
  • China’s Stocks Rise to Seven-Week High as Trading Volumes Surge
  • Japan Biotech Firms Jump as Abenomics Cash Spurs Speculation
  • Lundbeck-Takeda Drug Fights Depression Better at Higher Dose
  • SAC Says Cooperation With U.S. No Longer ‘Unconditional’
  • Credit Swaps in U.S. Fall as Leading Indicators, Sentiment Rise
« Previous 1 2 3 4 5 Next »